Tandem Diabetes Care Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Tandem Diabetes Care Inc 's ROA in the second quarter of 2026?
Tandem Diabetes Care Inc recorded a cumulative net loss of $-63 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -6.23%.

However, within the Healthcare sector 267 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3188, from total ROA ranking in the first quarter of 2026 at 4130.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	31.8 %	25.08 %	-0.23 %	0.43 %	3.03 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-63	-95	-205	-203	-205
Return On Assets (TTM)	-6.23 %	-9.99 %	-23.04 %	-22.88 %	-23.14 %
TNDM's Total Ranking	# 3188	# 4130	# 3591	# 3626	# 3607
Total Assets (TTM) in million	1,154	1,153	881	875	876
Seq. Total Assets Change	0.07 %	30.9 %	0.74 %	-0.12 %	-5.03 %
Seq. Net Income Change	-	-	-	-	-

TNDM's 5 Years Annual ROA >> Back to TNDM Management Effectiveness >> Compare TNDM ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 84
Sector	# 268
Overall	# 3019

Return On Assets Statistics
High	Average	Low
9.99 %	-32.37 %	-98.34 %
(Jun 30 2011)		(Jun 30 2018)

Financial Statements
Tandem Diabetes Care Inc 's Assets	$ 1,154 million	TNDM's Balance sheet
Tandem Diabetes Care Inc 's Income	$ -21 million	Quarterly TNDM's Income Statement
TNDM's Income by Division		See TNDM's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	6.6 %	1.92 %	-8.16 %	7.35 %	26.05 %
Total Assets in million	941	883	867	944	879
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-205	-96	-223	-95	16
Annual Return On Assets	-21.74 %	-10.87 %	-25.69 %	-10.03 %	1.77 %

TNDM's 5 Years Annual ROA >> Back to TNDM Management Effectiveness >> Compare TNDM ROA to its Competitors

More Return On Assets Ratios
TNDM's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TNDM's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TNDM's Competitors
Subscribers only: Roa for Tandem Diabetes Care Inc 's Suppliers
Subscribers only: Return On Assets for TNDM's Customers

You may also want to know
TNDM's Roi	TNDM's Inventory Turnover Ratio	TNDM's Growth Rates	TNDM's Dividend Comparisons
	TNDM's Profitability Ratios	TNDM's Asset Turnover Ratio	TNDM's Dividend Growth
TNDM's Roe	TNDM's Valuation Ratios	TNDM's Financial Strength Ratios	TNDM's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T06:58:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.